Generation of hybridomas producing human monoclonal antibodies against human cytomegalovirus.
In vitro stimulation of human lymphocytes were studied in connection with cell fusion. When splenic lymphocytes were stimulated with human cytomegalovirus (CMV), they produced IgG but not IgM antibody against CMV. The stimulation with 50 ng/ml of CMV antigen induced the maximum antibody response, and higher concentrations of CMV antigen decreased antibody response and increased nonspecific IgG production. Human splenic lymphocytes were stimulated for 6 days with CMV antigen (50 ng/ml) and/or B-cell growth factor (BCGF), and then fused with mouse myeloma cells. Stimulation with a combination of antigen and BCGF were able to generate CMV-specific hybridomas synergistically. Two of these hybridomas were cloned by limiting dilution. The human monoclonal antibodies produced by them, C1 and C23, bound to CMV but not to other herpesviruses. C23 neutralized virus infectivity C1 did not at all. This method for generation of hybridomas producing human monoclonal antibodies against a predefined antigen may be applicable to a variety of viral antigens.
D000911:Antibodies, Monoclonal / Q000276:immunology*; D000918:Antibody Specificity; D002478:Cells, Cultured; D003587:Cytomegalovirus / Q000276:immunology*; D006133:Growth Substances / Q000494:pharmacology; D006801:Humans; D015847:Interleukin-4; D008222:Lymphokines / Q000494:pharmacology; D009500:Neutralization Tests; D013997:Time Factors
D000911:Antibodies, Monoclonal; D006133:Growth Substances; D008222:Lymphokines; D015847:Interleukin-4